RACHESKY MARK H MD

Mark H. Rachesky, MD, has demonstrated a consistent buying bias across his reported insider transactions, with no recorded sales in his SEC Form 4 filings. His activity spans three companies—Titan International (TWI), Star Equity Holdings (STRZ), and Lionsgate Entertainment (LION)—with a total buy value exceeding $5.5 million. Notably, his largest transactions were concentrated in STRZ, including a $4.42 million purchase on June 2, 2025, followed by an additional $582,895 acquisition the same day. More recently, he acquired shares in TWI worth $139,900 on February 9, 2026, and STRZ shares valued at $50,001.56 on January 27, 2026. Earlier, in late November 2025, he made two separate purchases in LION totaling $226,000. The absence of sell-side activity suggests a long-term accumulation strategy, particularly in STRZ, which accounts for the bulk of his investment. While some filings with zero-dollar values—primarily coded as "J" for other transactions—indicate non-monetary adjustments, his cash-based acquisitions remain the dominant trend. The recent purchases in early 2026 reinforce this pattern, with Rachesky continuing to add positions in TWI and STRZ. The data reflects a clear directional bias toward building stakes rather than liquidating, though the concentration in smaller-cap names like STRZ and TWI may indicate a focus on niche or turnaround opportunities.